Magnetic Bead Handling Using a Paper-Based Device for Quantitative Point-of-Care Testing
Kevin Arias-Alpízar1,2, Ana Sánchez-Cano1,2, Judit Prat-Trunas1
1Diagnostic Nanotools Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
Biosensors
|September 23, 2022
Summary
This study introduces a novel microfluidic paper-based analytical device (μPAD) for rapid malaria diagnosis. The affordable μPAD automates a magneto-immunoassay, enabling sensitive Plasmodium falciparum lactate dehydrogenase (Pf-LDH) detection at room temperature.
Area of Science:
- Analytical Chemistry
- Biomedical Engineering
- Point-of-Care Diagnostics
Background:
- Microfluidic paper-based analytical devices (μPADs) offer potential for point-of-care (POC) testing.
- Existing μPADs often rely on dried reagents, leading to production, stability, and storage challenges.
- Room temperature storage and simplified manufacturing are critical for widespread POC adoption.
Purpose of the Study:
- To develop an affordable, room-temperature-storable μPAD for partially automating magneto-immunoassays.
- To demonstrate the μPAD's utility for quantitative detection of Plasmodium falciparum lactate dehydrogenase (Pf-LDH), a malaria biomarker.
- To assess the device's performance against established diagnostic methods.
Main Methods:
- Fabrication of μPADs using a craft cutter for affordability and ease of production.
- Implementation of a single-step colorimetric magneto-immunoassay involving magnetic beads (MB), antibodies, and an enzymatic amplifier.
- On-chip magnetic concentration and washing of MBs, followed by colorimetric signal generation and readout via naked eye or smartphone imaging.
Main Results:
- Quantitative detection of Pf-LDH achieved in under 15 minutes.
- Detection limits of 6.25 ng mL−1 (naked eye) and 1.4 ng mL−1 (smartphone imaging).
- Clinical sample analysis showed correlation with ELISA and superior sensitivity compared to commercial rapid diagnostic tests (RDTs).
Conclusions:
- The developed μPAD enables partial automation of magneto-immunoassays, meeting key requirements for POC testing.
- The device offers a stable, room-temperature-storable, and affordable platform for malaria diagnosis.
- This approach significantly enhances the potential of μPADs for accessible and sensitive disease detection.


